Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 20 IN PLASTIC CONTAINER versus DEXTROSE 5 AND POTASSIUM CHLORIDE 0 3 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 20 IN PLASTIC CONTAINER versus DEXTROSE 5 AND POTASSIUM CHLORIDE 0 3 IN PLASTIC CONTAINER.
DEXTROSE 20% IN PLASTIC CONTAINER vs DEXTROSE 5% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose is a monosaccharide that serves as a source of calories and water for parenteral nutrition. It is oxidized to carbon dioxide and water, providing energy. Administration of hypertonic dextrose solutions increases blood glucose levels, which can stimulate insulin secretion and promote cellular glucose uptake.
Dextrose provides a source of calories and energy by entering the glycolytic pathway and being metabolized to carbon dioxide and water. Potassium chloride replenishes potassium ions, which are essential for nerve impulse conduction, muscle contraction, and maintaining intracellular osmotic pressure.
Intravenous infusion; adult dose: 500-1000 mL of 20% dextrose solution (100-200 g dextrose) administered over 1-2 hours; maximum infusion rate: 0.5 g/kg/hour. Frequency: as needed for hypoglycemia or as part of parenteral nutrition.
Intravenous infusion of potassium chloride 0.3% in dextrose 5% at a rate determined by potassium deficit and patient tolerance, typically 10-20 mEq per hour; maximum infusion rate 40 mEq/hour in non-emergency situations.
None Documented
None Documented
Plasma half-life is approximately 2-5 minutes under normal conditions due to rapid cellular uptake and metabolism; prolonged in hyperglycemic states or renal impairment.
Not applicable as a single drug; potassium's terminal half-life ~12-24 hours (depends on total body stores and renal function); dextrose half-life ~15-20 minutes (highly variable with insulin response). Clinical context: half-life relevant only for potassium monitoring in renal impairment.
Dextrose is completely metabolized to carbon dioxide and water via glycolysis and the citric acid cycle; negligible renal excretion of unchanged drug. <1% excreted unchanged in urine.
Potassium: >90% renal excretion. Dextrose: metabolized to CO2 and water; no significant renal excretion of intact glucose unless hyperglycemia exceeds renal threshold.
Category C
Category C
IV Fluid
IV Fluid